Access this stock data via API
Subscribe
Edwards Lifesciences Corporation
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 1.3B 1.3B 1.2B 1.2B
Cost of revenue 294.2M 293.5M 257.0M 249.0M
Gross profit 1.0B 1.0B 946.9M 932.0M
Operating expense
Research & development 239.2M 235.4M 217.0M 231.0M
Selling general and admin 438.6M 427.8M 396.9M 419.2M
Other operating expenses -10.7M -18.2M -16.3M -19.3M
Operating income 362.3M 367.2M 349.3M 301.1M
Non operating interest income
Income 32.9M 31.9M 54.5M
Expense
Other income expense -98.3M -58.0M -10.7M -6.3M
Pretax income 296.9M 341.1M 369.8M 332.5M
Tax provision 47.8M 54.8M 59.9M 38.4M
Net income 247.4M 282.5M 303.7M 327.5M
Basic EPS 0.6 0.6 0.7
Diluted EPS 0.6 0.6 0.7
Basic average shares 500.3M 500.2M 502.7M
Diluted average shares 501.0M 501.0M 503.3M
EBITDA 496.3M 456.6M 393.4M 394.5M
Net income from continuing op. 247.4M 282.5M 303.7M 327.5M
Minority interests 681.8K -1.4M 1.4M 1.1M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 8 hours 5 minutes

23:54
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).